Illumina, Inc. (ILMN)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$239.62
-2.32%
Mkt Cap $36.25B
Analyst Ratings
Buy
14
Hold
5
Sell
5
Price Target (71 analysts)
$156.27
Range $122.00 – $200.00
Implied Upside
-34.8%
Consensus $156.27 vs current $239.62